Skip to content
Screener

Alumis Inc. ALMS Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.39B-13.4%
Amgen logo
AmgenAMGN
$4B+75.5%
Immunome logo
ImmunomeIMNM
-$58.64M-10.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$23.58M-13.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.99M-75.5%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$56.67M-25.3%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Research and development accrued expenses1,1785,550
Other accrued expenses and current liabilities(9,716)4,988
Operating lease liabilities(1,249)(617)
Net cash used in operating activities(87,082)(80,355)
Cash flows from investing activities
Maturities of marketable securities142,86264,000
Purchases of marketable securities(428,384)(24,535)
Purchases of property and equipment(164)(37)

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s operating cash flow?
Alumis Inc. (ALMS) reported operating cash flow of -$87.08M in Q1 2026.
How has Alumis Inc.'s operating cash flow changed year-over-year?
Alumis Inc.'s operating cash flow decreased by 8.4% year-over-year, from -$80.36M to -$87.08M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Alumis Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude